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Randomized Controlled Trial Comparing
Orthosis Augmented by Either Stretching
or Stretching and Strengthening for
Stage II Tibialis Posterior Tendon
Dysfunction
Jeff Houck, PT, PhD1, Christopher Neville, PT, PhD2, Josh Tome, MS4,
and Adolph Flemister, MD3

Abstract
Background: The value of strengthening and stretching exercises combined with orthosis treatment in a home-based
program has not been evaluated. The purpose of this study was to compare the effects of augmenting orthosis treatment
with either stretching or a combination of stretching and strengthening in participants with stage II tibialis posterior tendon
dysfunction (TPTD).
Methods: Participants included 39 patients with stage II TPTD who were recruited from a medical center and then
randomly assigned to a strengthening or stretching treatment group. Excluding 3 dropouts, there were 19 participants in
the strengthening group and 17 in the stretching group. The stretching treatment consisted of a prefabricated orthosis
used in conjunction with stretching exercises. The strengthening treatment consisted of a prefabricated orthosis used
in conjunction with the stretching and strengthening exercises. The main outcome measures were self-report (ie, Foot
Function Index and Short Musculoskeletal Function Assessment) and isometric deep posterior compartment strength.
Two-way analysis of variance was used to test for differences between groups at 6 and 12 weeks after starting the exercise
programs.
Results: Both groups significantly improved in pain and function over the 12-week trial period. The self-report measures
showed minimal differences between the treatment groups. There were no differences in isometric deep posterior
compartment strength.
Conclusions: A moderate-intensity, home-based exercise program was minimally effective in augmenting orthosis wear
alone in participants with stage II TPTD.
Level of Evidence: Level I, prospective randomized study.
Keywords: rehabilitation, tendinopathy, foot
Tibialis posterior tendon dysfunction (TPTD) is a common
tendinopathy that is associated with adult acquired flatfoot
deformity.6,11,13,22 Therapeutic options for stage II TPTD
entail nonoperative care with bracing and exercise or operative management.7,20,21,30,31 The severity of TPTD may
affect the choice of nonoperative or operative treatment.
Stage II TPTD is characterized by signs of tendinopathy
(ie, pain and swelling along the tendon) in the presence of
a passively correctable foot deformity or loss of the medial
longitudinal arch.13 Stage II TPTD is associated with a
wide range of weakness, foot deformity, and functional
problems.17,33,34 Ultimately, relatively few participants
with TPTD, 12.5% to 27% in recent studies, elect operative
management.28,30 The low use of operative management of

TPTD emphasizes the need to optimize nonoperative
treatments.
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Orthosis prescription, including above-ankle and belowankle orthoses, are the most commonly recommended nonoperative treatment.28 Uncontrolled studies note that
participants experience a decrease in pain and improved
function when using orthoses.1,2,14,17,20 Further, long-term
(4- to 8-year) follow-up of orthoses suggested that 60.6% of
participants were “satisfied.” However, the average initial
length of orthosis wear was 14.9 months, and 36% of the
participants returned to wearing their orthosis at some time
during the follow-up period. Intermittent continuing use of
an orthosis suggests unresolved symptoms over prolonged
periods. Two unaddressed issues are (1) whether some
orthosis strategies are more effective than others and (2)
whether other treatments, such as exercise, augment orthosis use.
A prefabricated clamshell orthosis may be cost-effective
and adequate for foot support in patients with TPTD. A
kinematic study showed that a prefabricated clamshell
orthosis limited hindfoot eversion and raised the medial
longitudinal arch.27 These same movements in a cadaver
study demonstrated unloading of the tibialis posterior tendon.23,26 These positive kinematic findings are coupled with
positive outcomes in studies that use the prefabricated
clamshell orthoses.14 Considering the markedly lower cost
of the prefabricated clamshell orthosis and the demonstrated clinical benefits,14 this type of orthosis was considered a good choice for clinical management.
The conflicting evidence regarding whether exercise
augments orthosis wear in patients with stage II TPTD
stems from varying study design (uncontrolled vs controlled trials), orthosis use (wide range), and exercise dosage. First, uncontrolled trials demonstrate the potential
benefit of combining an orthosis and exercise programs for
stage II TPTD.1,16 However, only 1 of 2 controlled trials
demonstrated a similar benefit.17 Second, orthotic designs
that restrict ankle and foot motion may induce muscle disuse.25 Whether combining exercise with less restrictive
orthoses maintains muscle function and similar clinical
benefits is unclear. Third, the optimal intensity of training is
undetermined. One uncontrolled trial suggested marked
improvements as a result of high-intensity training.1 Two
randomized controlled trials3,17 included lower dosage
training and did not replicate the positive results of a highintensity dosage.1 Untested is the effect of a program that
may be easily used in the clinic with moderate-intensity
exercise to improve muscle weakness and improve painfree function.
The purpose of this study was to examine the effects of
strengthening treatment combined with orthosis and stretching compared with the effects of orthosis and stretching
alone in participants with stage II TPTD. The dosage for the
strengthening treatment group was as high as possible with
the limit being that the exercises would need to primarily be
performed in the home and within patient tolerance.

Methods
Participants
From spring 2007 to summer 2009, a total of 88 participants
were screened for participation in this study. Of the 88 participants who were screened, a total of 39 were admitted to
the study. A power analysis, based on pilot data on strength
and self-reported outcomes, suggested that a sample size of
20 per group would provide greater than 80% power to detect
differences between the groups at an effect size equal to 0.75
the standard deviation of the measures used. Recruitment
was conducted at a university medical clinic by a foot and
ankle fellowship–trained physician. To qualify for the study,
participants met the following criteria to be diagnosed with
stage II TPTD: (1) presence of either pain or swelling along
the course of the tibialis posterior tendon and (2) presence of
correctable flatfoot deformity. Participants also had to be able
to walk 15 m and were required to be older than 40 years.
Participants were excluded if (1) they were unable to walk 15
m, (2) a test using Semmes-Weinstein 5.06 monofilament
showed decreased sensation, (3) participants had an arch
height index of less than 0.255 (2 SD below arch height index
of controls),5 (4) participants were unable to assume subtalar
neutral posture, or (5) they had bilateral TPTD. Participants
with inflammatory arthropathies (rheumatoid arthritis, psoriasis) and comorbidities for foot conditions (hallux rigidus,
plantar fasciitis) were also excluded. Participants signed a
consent form approved by the institutional review board at
the University of Rochester and Ithaca College. This clinical
trial was registered at ClinicalTrials.gov in 2008.

Randomization and Blinding
A stratified block randomization protocol was used to assign
participants to the stretching or strengthening group.
Participants were stratified, according to their Foot Function
Index (FFI) Total score, into moderate/severe (FFI-Total 20
or more) and minimal (FFI-Total less than 20) categories.
Participants in the moderate/severe and minimal groups were
randomized separately into the stretching (orthosis and
stretching) and strengthening (orthosis, stretching, and
strengthening) groups to ensure equal distribution on severity
of the FFI-Total score. Allocation was not concealed.
However, to ensure randomization, an independent investigator tracked the assignment to groups throughout the experiment. Once participants were admitted to a particular study
protocol, all participants were told they were in the intervention group. However, the treating therapist administered both
interventions.

Interventions
Stretching Group (Orthosis and Stretching). All participants
were provided and fit with an orthosis (AirLift TPTD,
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Aircast, DJO Global Inc, Vista, CA) that includes an ankle
stirrup support and medial longitudinal arch support, commonly used for TPTD. The prefabricated orthosis has demonstrated validity for improving foot kinematics during
walking.25 In addition to wearing the orthosis during all
weight-bearing activities, participants were provided with
written descriptions and pictures demonstrating exercises
that included a wall calf stretch and a supine ankle active
range of motion exercise. The wall calf stretch included a
knee-extended gastrocnemius stretch and a knee-flexed
soleus stretch. For the foot and ankle active range of motion
stretch, instructions were to point the big toe down (ie, plantar flexion) while moving it toward the other foot (ie, inversion) and then point the toe up (ie, dorsiflexion) and away
from the other foot (ie, eversion). This movement is known
to stretch the tibialis posterior muscle.9 It is also anecdotally
associated with pain relief. Participants were instructed to
perform 3 sets of the stretching exercises, 2 times a day.
Each stretching exercise was performed twice and held for
30 seconds. The effects of these 2 exercises were not
expected to cause muscle hypertrophy.
Strengthening Group (Strengthening Combined With Orthosis
and Stretching). The strengthening exercises included a progression of 3 exercises that were meant to restore the ability
of participants with TPTD to perform a single-leg heel raise
(see the Appendix in the online Supplemental Materials).
1.
2.

3.

Bilateral heel raises (standing)
Ankle plantar flexion with foot adduction and hindfoot inversion (side-lying or seated) with elastic
bands (Thera-Band, Hygenic Corporation, Akron,
OH).
Unilateral heel raises (standing)

The focus for each of the strengthening exercises was to
progressively load the tibialis posterior tendon and ankle
plantar flexors. This included both eccentric and concentric
contractions during the elastic band exercise and a deliberate focus on raising the arch and inverting the hindfoot during the heel-raise exercises. A recent study noted moderate
contribution of the tibialis posterior muscle during a heel
raise.15 The seated elastic band exercise for the subtalar
inverters complied with published recommendations.10
Participants sat cross-legged with the ankle plantar flexed.
An elastic band was wrapped around the forefoot and
anchored with the opposite leg on the floor. Participants
were then asked to invert and adduct their foot against the
resistance of the band, effectively raising their foot toward
the ceiling. They were taught not to substitute with their
tibialis anterior muscle. Participants were encouraged to
exercise to exhaustion against the heaviest resistance bands
that could be provided and perform the heel-raise exercises

to the target number and height. Participants were progressed at each visit they attended throughout the program
so long as they (1) could execute the exercise and (2) did
not experience significant pain in the tibialis posterior tendon. The goal was for participants to progress to 3 sets of 30
repetitions, 2 times per day for each exercise. Participants
were told that muscle soreness in the leg was a normal
response to the exercise. The participants in the strengthening group (orthosis and strengthening) performed the same
exercises as the stretching group as well as the strengthening exercises.
Participants in both the stretching and strengthening
treatment groups were seen a total of 7 sessions (initial,
week 1, week 2, week 3, week 4, week 5, and week 6). The
initial visit was used to complete tests and orient participants to the exercises, and the week 1 to week 3 sessions
were used to teach correct technique and progress resistance
as indicated. The week 4 through week 6 sessions were used
to answer questions and encourage compliance and progression. From week 6 until the follow-up at 12 weeks, participants were encouraged to continue with their exercises
independently. All sessions, for both the stretching and
strengthening groups, lasted approximately 30 minutes,
ensuring that both groups received approximately the same
amount of attention.
A compliance log was used to encourage follow-through
and record orthosis wear and exercise sets. At the end of
study participation, the compliance log was collected, and
the hours of orthosis wear and sets completed were tallied.
The number of wear hours and number of sets performed by
each participant were divided by the total possible orthosis
wear hours (8 hours per day × total days [12 weeks × 7 days
per week]) and total sets possible (2 sets per day × total days
[12 weeks × 7 days per week]). Each participant’s total
brace wear time and sets completed were then expressed as
a percentage of total possible to document compliance.

Outcome Variables
Foot Function Index. The FFI is a validated questionnaire
previously used to document outcomes in TPTD.2-4 The
test-retest reliability, internal consistency, and factor analysis of the original scale support the construct validity for
patients with TPTD.4,8,19,29 The 3 domains of the FFI include
pain (FFI-Pain), disability (FFI-Disability), and activity
limitations (FFI-Activity Limitations). Each category asks
participants to rate items relative to pain. The average of the
3 scales is the FFI-Total. The reported minimal clinically
important difference is 12.3 mm for FFI-Pain, 6.7 mm for
FFI-Disability, undetermined for FFI-Activity Limitations,
and 6.5 mm for FFI-Total.18
Short Musculoskeletal Function Assessment. The Short Musculoskeletal Function Assessment (SMFA) is a self-report
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questionnaire consisting of the Mobility Index, Dysfunction
Index, and Bother Index. The Dysfunction Index is used to
assess patients’ perceptions of their functional performance,
while the Bother Index is used to assess participants’ perceptions of how much they are bothered by problems. The
Mobility Index is a subset of questions specific to community ambulation. Note that pain is not mentioned in the
questionnaire, making this outcome distinct from the FFI.
The scale was originally validated in participants who had
acute fracture or soft tissue injury.32 The responsiveness to
change of the SMFA is 10 points out 100 for each scale
(function, Mobility, and Bother Indexes).32

Isometric Deep Posterior Compartment Strength
Maximal efforts of isometric deep posterior compartment
were used to document strength. A custom-made isometric
strength testing system that isolated the deep posterior compartment by resisting foot adduction was used.12 A force
transducer (Model SML-200, Interface, Scottsdale, AZ),
connected in series with a resistance plate and oscilloscope
(TDS 410A, Tektronix, Beaverton, OR) was used to display
force readings. Participants were seated with their leg in an
air stirrup brace (Aircast Inc) mounted on uprights. The air
stirrup brace was adjusted so the heel was approximately 10
cm above the resistance plate, resulting in 30 to 45 degrees
of ankle plantar flexion depending on foot length. The resistance plate was mounted on ball-bearing tracks in the
medial-lateral direction, and moleskin was used to fit to the
general shape of the medial forefoot. The result was that
participants could exert maximum effort against the resistance plate (medial direction) with little discomfort.
Visual feedback of the amount of force exerted and electromyography of the tibialis anterior muscle for each effort
was used to encourage participants to exert maximal efforts
and minimize contribution of the tibialis anterior. A surface
electrode (DE-2.1, Delsys Inc, Boston, MA) placed over the
tibialis anterior was tracked using electromyography
(Bangoli-2 EMG System, Delsys Inc) and displayed on the
oscilloscope. The force and muscle activity results were
used to provide feedback to the examiner and participants.
Participants were instructed to “press down and in” to
reproduce a maximum plantar flexion, subtalar inversion,
and forefoot adduction effort. To track substitution by the
tibialis anterior muscle, electromyography was used.
Maximal ankle dorsiflexion efforts were recorded and used
to calculate 10% of the maximum peak to peak electromyographic signal. During 5 submaximal efforts, if tibialis anterior muscle activity was high (exceeded 10% of maximum
voluntary contraction), participants were given verbal cues
to reduce tibialis anterior muscle activity (push down harder
and/or push medially with their forefoot), diminishing the
contribution of the tibialis anterior muscle. After the practice trials, visual feedback of the force and verbal

encouragement were used to motivate participants to exert
3 maximal efforts. The average of the peak force was used
to document the peak isometric deep posterior compartment
strength. A previous study demonstrated adequate reliability with intraclass correlation coefficients above 0.87 and a
standard error of measurement of 0.14 N/kg.12

Statistical Analysis
Two-way mixed-effect analysis of variance (ANOVA) models were used to analyze differences between groups on the
dependent variables (ie, self-report scores and isometric
deep posterior compartment strength). The 2 factors of each
model were time and group. Time included 3 time points
(initial, 6 weeks, and 12 weeks). The second factor, group,
included 2 levels designated the strengthening and stretching groups. Differences between interventions at either time
point (6 weeks or 12 weeks) were consistent with significant
interaction effects (group × time). In the presence of a significant main effect for time, pairwise comparisons between
time points were completed (initial, 6 weeks, and 12 weeks).
To further investigate comparisons between the groups,
changes between each of the time points (initial to 6 weeks,
initial to 12 weeks, and 6 weeks to 12 weeks) were calculated. Further, the percentage of participants who made
improvements on the FFI above a minimal clinically important difference, and on the SMFA equal to or above responsiveness (10 points), were identified and compared using a
nonparametric chi-square analysis. For deep posterior compartment strength, the standard error of the measurement
(0.14 N/kg) was used to determine improvements in strength.
An alpha level of .05 was used for each analysis. The dependent variables analyzed included the subscales of the FFI
(Activity Limitations, Disability, Pain, and Total), subscales
of the SMFA (Mobility, Function, and Bother Indexes), and
isometric deep posterior compartment strength.

Results
Recruitment and Retention
Eighty-eight participants were screened for the study, with
39 meeting the study criteria (Figure 1). Of the 39 participants, 20 were randomized to the strengthening treatment
group while 19 were randomized to the stretching treatment
group. There were no significant differences between any of
the subjects’ initial characteristics (Table 1). One participant in the strengthening treatment group decided to have
surgery after the 2-week follow-up (Figure 1). In the stretching group, 2 participants were lost between the 6- and
12-week follow-ups. Data for these 3 participants were not
included in the final analysis. Compliance for completing 2
sets of exercise per day for the 12 weeks of the study for
both of the groups ranged from 29% to 126% (average
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Assessed for eligibility, n = 88
Excluded n = 49

Enrollment

Allocaon

Inclusion Criteria Not met(see
text for details);
(Presence of comorbidity n=20,
Decreased sensaon n=4, Arch
height index n=4, Rheumatoid,
Arthris n=4, Subtalar neutral
n=8, Not interested n=9)

Enrollment and randomizaon,
n = 39

Passive Treatment (brace and
stretching), n = 19

Acve Treatment (Brace and
Strengthening), n = 20

Week 1 follow-up

Completed session, n = 19

Week 2 follow-up

Completed session, n = 19

Week 3 follow-up

Completed session, n = 19

Completed session, n = 19

Week 4 /5 follow-up

Completed session, n = 19

Completed session, n = 19

Completed session, n = 19

6 Week Follow-up, n = 19

6 week follow- up

12 week follow-up

Completed Session, n = 17

Lost to follow-up, n = 2 (moved overseas and CA
treatment resumed)

Completed session, n = 20

Completed session, n = 19

Lost to Follow-up, n=1 (decided to have surgery)

12 Week Follow-up, n = 19

Figure 1. Consolidated Standards of Reporting Trials flow chart.

79%) for all participants completing the study. Compliance
for wearing the orthosis ranged from 6 to 15 hours per day
(average 9.9 hours). There were no significant differences
between the groups in compliance with exercise or orthosis
wear. Additionally, there were no recorded adverse events
from exercise (extreme muscle soreness, increase medial
ankle pain) or orthosis wear (blisters, calluses, increased
pain). All participants were analyzed in the groups to which
they were originally assigned, and data collection was terminated when study sample approximated the anticipated
recruitment goals.

12-week time points were associated with significantly better scores compared with initial scores. However, there
were no significant differences between the 6-week and
12-week time points for any of the FFI dependent variables.
There were also no significant differences in change scores
between the strengthening and stretching groups associated
with the FFI from initial to 6 weeks or from initial to 12
weeks (Table 3). Change scores on the FFI were similar
from 6 to 12 weeks. The proportions of participants experiencing a significant change was not significant for all intervals assessed for the FFI.

Foot Function Index

SMFA Questionnaire

For all FFI dependent variables, there were significant main
effects for time, indicating that both groups improved over
time (Table 2). For all FFI dependent variables, 6- and

For all SMFA dependent variables, there were significant
main effects for time, indicating that both groups improved
over time (Table 2). For all SMFA dependent variables, 6- and
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Table 1. Comparison of Patient Characteristics, Foot Posture,
Gait, and Self-Report of the Stretching Group (n = 17) and the
Strengthening Group (n = 19) at the Initial Visit.
Stretching
Groupa

Strengthening
P Valueb
Groupa

Patient characteristics
Age
58 ± 9
57 ± 12
Height, cm
167 ± 9
166 ± 9
Weight, kg
87 ± 15
82 ± 18
31 ± 5
30 ± 6
Body mass index, kg/m2
Male sex, n
4
4
Left side involvement, n
11
13
Foot posture
Arch height index
0.32 ± 0.03 0.32 ± 0.02
Gait
Walk speed, m/s
1.1 ± 0.1
1.0 ± 0.1
Self-report
Foot Function Index
Activity Limitations
13 ± 12
16 ± 11
Disability
31 ± 16
40 ± 20
Pain
35 ± 11
38 ± 18
Total
26 ± 10
31 ± 13
Short Musculoskeletal Function Assessment
Mobility
22 ± 12
27 ± 14
Dysfunction
17 ± 9
22 ± 12
Bother
23 ± 16
26 ± 20

.14
.99
.43
.09
.62c
.45c
.20

compliance and FFI scales or compliance and SMFA
scales were all weak and nonsignificant (r < 0.14).

Isometric Deep Posterior Compartment Strength
No significant interactions were detected between time and
group for isometric deep posterior compartment strength,
nor was there a main effect for time (Table 4). There were
also no significant differences in change scores for isometric deep posterior compartment strength for any of the intervals tested (Table 5). The proportion of participants who
experienced improvement above a standard error of the
measurement in strength was not significantly different in
the strengthening group on the involved or uninvolved sides
for any of the intervals tested.

.45

Discussion
.60
.10
.08
.22
.56
.38
.81

a

Values expressed as mean ± standard deviation, except for male sex
and left side involvement.
b
P values are from 2-sample t test for all comparisons, except those
noted with “c.”
c
Chi-square test was used for these comparisons.

12-week time points were associated with significantly better scores compared with initial scores. However, there were
no significant differences between the 6-week and 12-week
time points for any of the SMFA dependent variables. In
contrast to the FFI, between initial visit and 6 weeks, the
change scores of the Mobility Index and Dysfunction Index
of the SMFA were significantly higher in the strengthening
group (Table 3). Further, the proportion of participants experiencing a 10-point change significantly favored the strengthening group (Table 3). Significantly more participants in the
strengthening group experienced an improvement above 10
points for the Mobility Index and Dysfunction Index compared with the stretching group from initial visit to 6 weeks.
The significant change scores from initial visit to 6 weeks on
the SMFA Mobility and Dysfunction Indexes were not
accompanied by a significant change in the Bother Index.
All other change scores from initial visit to 12 weeks for the
SMFA were nonsignificant.
Due to the range of compliance observed in the
strengthening and stretching groups, Pearson correlations
between compliance and the primary outcome measures
(FFI and SMFA) were explored. The relationships between

The new findings of this study are that a moderate-intensity,
home-based exercise approach minimally improves outcomes over orthosis alone in participants with stage II
TPTD. There were significant differences favoring the
strengthening treatment group associated with the Mobility
and Dysfunction Indexes of the SMFA at 6 weeks. These
improvements in mobility and function were not coupled
with improvements in pain (FFI scores) or strength. Both
groups improved during the initial interval of training from
0 to 6 weeks on the FFI and SMFA.
A positive effect of the strengthening treatment was
observed in the Mobility and Dysfunction Indexes of the
SMFA; however, this was not coupled with parallel
improvements in pain. During the initial 0- to 6-week period
when participants learned how to progress their exercises,
53% and 42% of the strengthening group improved their
Mobility and Dysfunction Index scores, respectively, on the
SMFA. This compared with only 18% and 12% for the
same 2 SMFA Indexes in the stretching group (Table 2).
Despite this effect on mobility, no differences between the
strengthening and stretching groups were observed in the
FFI scale or the Bother Index of the SMFA, which focus on
the effect of pain and bother, respectively. Gains in ankle
muscle strength or improved recruitment of muscles used
for mobility might explain these mobility findings, while it
may also be possible that increased mobility adversely
affects any reduction in pain that might result from the
strengthening program.
Alternatively, the strengthening treatment protocol may
have lacked sufficient intensity and length to capture treatment effects associated with pain and function in participants with stage II TPTD. Three studies, 1 controlled and 2
uncontrolled, demonstrated significant benefits of exercise
to augment orthosis treatment for stage II TPTD.1,17 In
these studies, the intensity of the exercise and the length of
the center-based treatments were greater than this study.

Downloaded from fai.sagepub.com at GEORGE FOX UNIVERSITY on September 2, 2016

1012

Foot & Ankle International 36(9)

Table 2. Comparison of Self-Report Scores of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Analysis of Variance
Stretching Groupa

Strengthening Groupa

Time

Interaction

.001
<.001
<.001
<.001

NS
NS
NS
NS

>.001
>.001
>.001

NS
NS
NS

b

Foot Function Index
Initial visit
Activity Limitations
13 (7-18)
Disability
31 (23-38)
Pain
35 (29-40)
Total
26 (21-31)
6 Weeks
Activity Limitations
8 (4-12)c
Disability
21 (15-27)c
Pain
21 (15-28)c
Total
17 (13-21)c
12 Weeks
Activity Limitations
7 (3-10)c
Disability
18 (12-24)c
Pain
18 (12-25)c
Total
14 (10-19)c
Short Musculoskeletal Functional Assessmentd
Initial visit
Mobility
22 (16-28)
Dysfunction
17 (12-21)
Bother
23 (15-31)
6 Weeks
Mobility
18 (13-24)c
Dysfunction
13 (9-16)c
Bother
14 (9-18)c
12 Weeks
Mobility
16 (12-19)c
Dysfunction
12 (9-15)c
Bother
12 (9-15)c

16 (11-21)
40 (31-49)
38 (29-46)
31 (25-37)
8 (4-12)c
21 (15-28)c
21 (14-27)c
17 (12-22)c
10 (4-16)c
24 (15-34)c
19 (11-27)c
18 (11-25)c

27 (20-33)
22 (17-28)
26 (17-35)
15 (10-20)c
13 (9-17)c
15 (9-21)c
17 (12-22)c
15 (10-19)c
16 (8-25)c

Abbreviation: NS, not significant (P > .05).
a
Values expressed as mean (95% confidence interval);
b
Foot Function Index values are reported in millimeters; lower scores indicate better function and less pain.
c
Indicates significantly different post hoc test (P < .05) from baseline.
d
Short Musculoskeletal Functional Assessment scores are reported as percentages; lower scores indicate better function.

Previous studies used either 10 weeks17 or 120 days (median
treatment period)1 of center-based treatment combined with
home exercise. This study used 6 center-based treatments
followed by 6 weeks of home exercise, approximately 50%
fewer center-based treatment sessions. The intensity of the
exercise was also higher in previous studies. For example, a
previous study16 used a custom-built jig with loaded springs
that were increased from 0.9 kg to 1.7 kg (concentric group)
or to 5.6 kg (eccentric group) over the study period of 10
weeks. Another study1 used high-repetition exercise and
isokinetic training coupled with large sets of heel raises and
toe walking to strengthen participants. The current study,
using a moderate-intensity home-based program that
included heel raises and resisted deep posterior compartment strengthening using elastic bands, did not replicate

improvements in pain and function observed in these previous studies. In summary, high-exercise intensity over a longer period of time (ie, greater than 10 weeks) may show
more definite benefits to participants with stage II TPTD.
The lack of increase in isometric deep posterior compartment strength (Table 4) may be associated with the
intensity of training or the lack of large side-to-side deficits in strength at the initial visit. Previous studies did not
document weakness specific to the tibialis posterior muscle.1,17 The initial average side-to-side ratio of deep posterior compartment strength was 88% and 87% in the
stretching and strengthening groups, respectively (Table
4). The near 90% side-to-side strength ratio in this study
sample suggests that this group had less side-to-side
strength deficit than documented in previous studies.1,17,24
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Table 3. Comparison of Self-Report Change Scores of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Mean Change (95% CI)
Stretching Group

Participants Improved, % (n)

Strengthening Group

Stretching Group

Strengthening Group

8 (2 to 14)
19 (12 to 26)
17 (10 to 24)
15 (9 to 20)

41 (7)
59 (10)
65 (11)

37 (7)
53 (10)
63 (12)

6 (0 to 13)
16 (7 to 25)
18 (10 to 27)
14 (7 to 20)

29 (5)
47 (8)
59 (10)

47 (9)
74 (14)
68 (13)

−2 (–5 to 2)
−3 (–10 to 4)
1 (–5 to 8)
−1 (–6 to 3)

18 (3)
12 (2)
24 (4)

5 (1)
16 (3)
21 (4)

11 (7 to 16)c
9 (6 to 13)c
11 (6 to 16)

18 (3)
12 (2)
35 (6)

53 (10)d
42 (8)d
47 (9)

10 (4 to 15)
8 (3 to 12)
9 (3 to 16)

29 (5)
24 (4)
35 (6)

53 (10)
32 (6)
42 (8)

−2 (–5 to 2)
−2 (–4 to 1)
−1 (–6 to 3)

24 (4)
6 (1)
12 (2)

5 (1)
5 (1)
11 (2)

a

Foot Function Index
From initial visit to 6 weeks
Activity Limitations
4 (2 to 7)
Disability
10 (5 to 15)
Pain
13 (7 to 20)
Total
9 (5 to 14)
From initial visit to 12 weeks
Activity Limitations
6 (3 to 9)
Disability
13 (7 to 19)
Pain
16 (8 to 24)
Total
12 (6 to 18)
From 6 to 12 weeks
Activity Limitations
2 (–1 to 4)
Disability
3 (–1 to 7)
Pain
3 (–4 to 10)
Total
3 (–1 to 6)
Short Musculoskeletal Functional Assessmentb
From initial visit to 6 weeks
Mobility
4 (2 to 5)
Dysfunction
4 (2 to 5)
Bother
9 (5 to 14)
From initial visit to 12 weeks
Mobility
7 (4 to 10)
Dysfunction
5 (3 to 7)
Bother
11 (6 to 16)
From 6 to 12 weeks
Mobility
3.0 (–1 to 7)
Dysfunction
1 (–1 to 3)
Bother
2 (–1 to 5)

a
Foot Function Index values are reported in millimeters (maximum 100). Minimal clinically important difference was used to calculate proportions as
follows: Activity Limitations, none used; Disability, 6.7; Pain, 12.3; and Total, 6.5.
b
Short Musculoskeletal Functional Assessment scores are reported as percentages (maximum 100). Responsiveness to change of 10 points was used to
calculate proportions for the Mobility, Dysfunction, and Bother Indexes.
c
Significantly different according to t test (P < .05).
d
Significantly different proportion according to chi-square test (P < .05).

Separate from the discussion of the intensity of exercise,
targeting participants with documented weakness may
result in greater muscle responses and, therefore, more
benefits to participants.
Use of a prefabricated orthosis and a stretching exercise
program decreased self-reported pain, reduced disability,
and increased activity in our sample of participants with
stage II TPTD. Across the FFI scales (subscales and total),
the stretching group improved between 4.4 and 18.4 mm
from the initial visit to 6 weeks (Table 3). Approximately
60% of participants in both groups experienced a greater
than 10-mm improvement in their FFI-Total from the initial
visit to 6 weeks (Table 3). We are unaware of any previous
studies that used this orthosis; however, comparisons of
other orthoses suggest that moderate improvements were

observed in the current study. The shorter length of the
study, differences in orthoses, and severity of TPTD are
important to consider when comparing this study with others that used orthosis strategies for TPTD. Interestingly, no
studies, long or short term, report pain elimination using
orthoses.1,2 The lack of resolution of symptoms, even with
long-term orthosis treatment (4-8 years), motivates further
research.
There are several significant limitations to this study
associated with study design, sample characteristics, and
alternative treatments. This stratified, randomized controlled trial blinded participants but not the treating therapist. Although this clinical trial restricted inclusion to
participants with stage II TPTD, there was reported variability in the degree of foot deformity, strength, and
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Table 4. Comparison of Strength Measures of the Stretching Group (n = 17) and the Strengthening Group (n = 19).

Initial visit
Stretching
Strengthening
6 weeks
Stretching
Strengthening
12 weeks
Stretching
Strengthening
Main effect—time
Interaction effect

Involved Side, N/kga

Uninvolved Side, N/kga

Ratio of Involved to Uninvolved

0.8 (0.7-0.9)
0.7 (0.6-0.8)

0.9 (0.81-1.0)
0.8 (0.7-0.89)

0.9 ± 0.3
0.9 ± 0.2

0.8 (0.7-1.0)
0.8 (0.7-0.9)

1.0 (0.9-1.1)
0.8 (0.8-0.9)

0.9 ± 0.2
0.9 ± 0.2

0.8 (0.7-0.9)
0.8 (0.7-0.9)
NS
NS

1.0 (0.9-1.1)
0.9 (0.8-0.9)
NS
NS

0.9 ± 0.2
0.9 ± 0.2
NS
NS

Abbreviation: NS, not significant (P > .05).
a
Values expressed as mean (95% CI).

Table 5. Comparison of Change in Strength of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Mean Change, N/kg (95% CI)
Involved Side
From initial visit to 6 weeks
Stretching
0.1 (–0.0 to 0.1)
Strengthening
0.1 (–0.0 to 0.2)
From initial visit to 12 weeks
Stretching
0.0 (–0.0 to 0.1)
Strengthening
0.1 (–0.0 to 0.2)
From 6 weeks to 12 weeks
Stretching
0.0 (–0.1 to 0.0)
Strengthening
0.0 (–0.1 to 0.1)

Participants Improved, % (n)

Uninvolved Side

Involved Sidea

Uninvolved Sidea

0.0 (–0.1 to 0.1)
0.0 (–0.1 to 0.1)

11 (2)
31.5 (6)

29.4 (5)
21.1 (4)

0.1(–0.1 to 0.2)
0.0(0.0 to 0.1)

29.4 (5)
36.8 (7)

35.2 (6)
21.1 (4)

0.0 (–0.1 to 0.1)
0.0 (–0.1 to 0.0)

5.9 (1)
26.3 (5)

17.6 (3)
10.5 (2)

a

Proportions were determined by 2 standard errors of the measurement.

symptoms.24 Differences in initial strength across various
studies may also affect study results. For example, a more
targeted sample of participants with documented weakness
at the start of the trial may have demonstrated improvements in response to exercise. The sample size was sufficient to detect effect sizes of 6.75 mm on the FFI-Total
(approximately equal to a minimal clinically important difference of 6.5 mm). However, the confidence intervals do
not exclude the possibility of a significant effect. For example, the confidence interval of the change scores for FFIPain from the initial visit to 6 weeks ranges from 10 to 26
points for the strengthening group (Table 3). Either a larger
sample or more defined sample criteria (ie, weaker participants at initial visit) may narrow the confidence intervals
and subsequently avoid a type II error. Further, the length of
the study was short and therefore does not take into account
gradual effects of the strengthening intervention that could
occur over time. Alternative interventions such as activity
limitation and immobilization alone were not separated as
treatment strategies in this clinical trial. In summary, study

design, sample characteristics, intervention intensity, and
alternative interventions are important considerations in
future clinical trials.
In conclusion, a moderate-intensity, home-based exercise program was minimally effective in augmenting orthosis wear alone in participants with stage II TPTD. The
improvements observed were smaller than those reported in
some previous controlled and uncontrolled clinical trials,
suggesting that positive effects on function and pain in
response to exercise may require higher intensity than this
home-based program for participants with TPTD.
Irrespective of the specific exercise protocol (ie, stretching
or strengthening), participants improved in pain and function in response to either a strengthening or a stretching
approach over a 12-week time period.
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